Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Aprepitant recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Aprepitant (4 total). Check the affected lots below.

Most common reason: Cross-contamination (1 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Aprepitant. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Aprepitant recalls on record

none so far in 2026; 4 on record, newest first
Class II · Moderate risk

Merck Emend

Presence of particulate matter: potential presence of metal particulates in the product.

Ongoing Particulate / foreign matter Merck Sharp & Dohme LLC NDC 0006-3066-03 D-0241-2026
Class II · Moderate risk

Aprepitant Capsule

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0781-2321-06 D-1027-2022
Class III · Low risk

Aprepitant Capsules

Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.

Terminated Failed specification Glenmark Pharmaceuticals Inc., USA NDC 68462-583-40 D-0349-2019
Class II · Moderate risk

Aprepitant active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-523-2015